Gelernter, Joel

Department of Genetics, Yale University School of Medicine, West Haven, CT, USA

Title	Year	PMID
Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.	2008	18828801
Influence of vascular endothelial growth factor variation on human hippocampus morphology.	2008	18707678
Interpopulation linkage disequilibrium patterns of GABRA2 and GABRG1 genes at the GABA cluster locus on human chromosome 4.	2008	17976953
Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene.	2008	17507911
Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples.	2007	17761687
CNR1 variation modulates risk for drug and alcohol dependence.	2007	17509535
Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration.	2007	17157269
Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans.	2007	17185388
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.	2007	17374034
Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA).	2007	17590536
Variation in GABRA2 predicts drinking behavior in project MATCH subjects.	2007	17949392
ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies.	2006	16237392
Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.	2006	16759340
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.	2006	16476706
Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence.	2006	16741937
Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence.	2006	16685648
Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.	2006	16952998
Genomewide linkage scan for opioid dependence and related traits.	2006	16642432
Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.	2006	17085484
Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia.	2006	17106427

Resolved affiliation

Department of Genetics, Yale University School of Medicine, West Haven, CT, USA

Raw imported affiliations (114)

Affiliation
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven; VA Connecticut Healthcare Center, West Haven. Electronic address: joel.gelernter@yale.edu.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, VA CT Healthcare Center, West Haven, CT, USA.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, West Haven, Connecticut.
Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA. joel.gelernter@yale.edu
From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm; the Departments of Genetics, Psychiatry, and Nutrition, University of North Carolina, Chapel Hill, N.C.; the Department of Psychiatry, Washington University School of Medicine, St Louis; the Norwegian Centre for Mental Disorders Research (NORMENT), K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Oslo and Oslo University Hospital, Oslo; the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark; the Center for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark; the Department of Biomedicine-Human Genetics, Aarhus University, Aarhus, Denmark; the Institute of Psychiatry, Psychology and Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, King's College London, London; the National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Trust, London; the Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland; the Institute of Human Genetics, University of Bonn, Bonn, Germany; the Department of Genomics, Life and Brain Center, Bonn, Germany; the Institute of Neuroscience and Medicine, Juelich, Germany; the Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis; the Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, N.Y.; the Department of Psychiatry, Yale University, New Haven, Conn.; the Department of Psychiatry and the Genetics Institute, University of Florida, Gainesville; the Department of Psychiatry, University of California-San Diego, La Jolla, Calif., the Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, and the Department of Psychiatry, Massachusetts General Hospital, Boston; the Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Mass.; and the MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, U.K.
Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Electronic address: joel.gelernter@yale.edu.
Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA. joel.gelernter@yale.edu.
University of Texas at Austin, Department of Psychology and Population Research Center, Austin, TX, USA.
US Department of Veterans Affairs, Department of Psychiatry, West Haven, CT, USA.
US Department of Veterans Affairs (VA) National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven.
VA Connecticut Healthcare Center, Psychiatry Service, West Haven, CT, USA.
VA Connecticut Healthcare Center, West Haven, CT, USA.
VA Connecticut Healthcare System, Psychiatry Service, West Haven, CT, USA.
VA Connecticut Healthcare System, Psychiatry Service, West Haven, CT, USA. joel.gelernter@yale.edu.
VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut 06516, USA. joel.gelernter@yale.edu
VA Connecticut Healthcare System, West Haven, Connecticut.
VA Cooperative Studies Program Coordinating Center, West Haven, Connecticut8Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut13Department of Psychiatry, VA Connecticut Healthcare Center, Yale University School of Medicine, West Hav.
VA CT Healthcare Center, West Haven, Connecticut.
VA CT Healthcare Center, West Haven, CT 06516, USA.
VA CT Healthcare Center, West Haven, CT, USA.